enVVeno Medical - Warrants (30/05/2023) Long Term Debt

The latest long-term debt for NVNOW is $100K as of June 2026. That compares with $510K in the prior-year period — down 79.6% year over year. Investors often review this figure alongside enVVeno Medical - Warrants (30/05/2023)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, NVNOW's long-term debt moved from $510K to $100K — a 79.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in enVVeno Medical - Warrants (30/05/2023)'s operating scale or balance-sheet position.

A long-term debt figure of $100K for NVNOW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NVNOW's long-term debt ($100K), review year-over-year change from $510K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack enVVeno Medical - Warrants (30/05/2023)'s long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.